Concepedia

Incidence and clinical features of post-injection endophthalmitis according to diagnosis

Nadim Rayess, Ehsan Rahimy, Chirag P. Shah, Jeremy D. Wolfe, Eric Chen, Francis Char DeCroos, Philip Storey, Sunir J. Garg, Jason Hsu

British Journal of Ophthalmology · 2015 · 62 citations · 16 references

DOI

Abstract

Endophthalmitis rates appear to be lower in eyes with RVO compared with diabetic eye disease and neovascular AMD, possibly due to impaired immunity in diabetics and waning immunity in the generally older AMD population.

References

16

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

Anne E. Fung, Philip J. Rosenfeld, Elias Reichel · British Journal of Ophthalmology · 2006 · 534 citations · Full text

, , +17

Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections.

Michel Moutschen, André Scheen, Pierre Lefebvre · PubMed · 1992 · 306 citations

, , +19

Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents

Chirag P. Shah, Sunir J. Garg, J.F. Vander et al. · Ophthalmology · 2011 · 228 citations

, , +8

Incidence of Endophthalmitis and Use of Antibiotic Prophylaxis after Intravitreal Injections

Crystal S.Y. Cheung, Amanda W.T. Wong, Alex Lui et al. · Ophthalmology · 2012 · 195 citations

, , +8

The Role of Topical Antibiotic Prophylaxis to Prevent Endophthalmitis after Intravitreal Injection

Philip Storey, Michael Dollin, John D. Pitcher et al. · Ophthalmology · 2013 · 161 citations

, , +10